Regeneron Pharmaceuticals Crashes 19% On A Surprise Sanofi-Tied Failure - Investor's Business Daily
08.06.2025 02:28
Regeneron stock crashed Friday after the company's Sanofi (SNY)-partnered COPD treatment unexpectedly failed in a Phase 3 study, likely limiting the companies' ability to file for approval.
Shares o… [+2012 chars]